PARKINSON KASALLIGIDA APOPTOZ JARAYONINING RIVOJLANISHIDA INTERLEYKINLARNING O‘RNI

https://doi.org/10.5281/zenodo.20488716

Authors

  • Egamqulova Madina Abdusalom qizi Mirzo Ulugʻbek nomidagi O‘zbekiston Milliy universiteti Jizzax filiali Author
  • Xolmamatova Nurxayot Sayfiddin qizi Mirzo Ulugʻbek nomidagi O‘zbekiston Milliy universiteti Jizzax filiali Author
  • To‘xtasinov Abdulaziz Abdunosir o‘g‘li Mirzo Ulugʻbek nomidagi O‘zbekiston Milliy universiteti Jizzax filiali Author
  • Anvarov Bobur Baxodir o‘g‘li Mirzo Ulugʻbek nomidagi O‘zbekiston Milliy universiteti Jizzax filiali Author

Keywords:

Parkinson kasalligi, neyrodegeneratsiya, rotenon, kognitiv testlar, lipidlar tarkibi, interleykinlar, eksperimental model

Abstract

Ushbu tadqiqotda retinol yuborish orqali kalamushlarda Parkinson kasalligining eksperimental modelini kuzatish, hayvonlardagi kognitiv oʻzgarishlarni testlar yordam hamda interleykinlar miqdori va bosh miya lipidlar tarkibini oʻrganish masalalari yoritilgan. O'rnatilgan immunitet Parkinson kasalliklari patogenezida kasallik va biokimyoviy koʻrsatkichlarning oʻrni hamda neyrodegeneratsiya jarayonlarida lipidlar bilan bogʻliq muammolarini davolashga xizmat qiladi.

Downloads

Download data is not yet available.

References

Raja M, Bentivoglio AR. Impulsive and compulsive behaviors during dopamine replacement treatment in parkinson’s disease and other disorders. Curr Drug Saf 2012;7:63e75.

Dagher A, Robbins TW. Personality, addiction, dopamine: insights from Parkinson’s disease. Neuron 2009;61:502e10.

Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 2007;64:212e6.

Kim J, Kim M, Kwon DY, Seo WK, Kim JH, Baik JS, et al. Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson’s disease. J Neurol 2013;260:429e37.

Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al.Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010;67:589e95.

Weintraub D, Nirenberg MJ. Impulse control and related disorders in Parkinson’s disease. Neurodegen Disord 2013;11:63e71.

Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007;64:1089e96.

Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease. Movement Disord 2009;24:1461e7.

Poletti M, Bonuccelli U. Impulse control disorders in Parkinson’s disease: therole of personality and cognitive status. J Neurol 2012;259:2269e77.

Downloads

Published

2026-05-15

How to Cite

Egamqulova , M., Xolmamatova , N., To‘xtasinov , A., & Anvarov , B. (2026). PARKINSON KASALLIGIDA APOPTOZ JARAYONINING RIVOJLANISHIDA INTERLEYKINLARNING O‘RNI: https://doi.org/10.5281/zenodo.20488716. Scientific Practical Conference, 1(2), 121-125. http://d-pressa.com/index.php/spc/article/view/801